Prostate Cancer
Molecularly targeted agents as radiosensitizers in cancer therapy-focus on prostate cancer - Abstract
August 29, 2013
Predictors of Gleason score upgrading in a large African-American population - Abstract
August 29, 2013
The Prostate Cancer Intervention Versus Observation Trial (PIVOT) in perspective - Abstract
August 29, 2013
Prostate-specific antigen testing: Men's responses to 2012 recommendation against screening - Abstract
August 29, 2013
Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxel - Abstract
August 29, 2013
New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical - Abstract
August 29, 2013
The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy - Abstract
August 29, 2013
Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer - Abstract
August 28, 2013
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer - Abstract
August 28, 2013
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease - Abstract
August 28, 2013